Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Structure

InChI Key RGFBRLNVZCCMSV-BIRGHMBHSA-N
Smile CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(N)n1
InChI
InChI=1S/C22H20N8O5S4/c1-3-35-27-13(16-26-21(23)39-28-16)17(31)25-14-18(32)30-15(20(33)34)12(9-36-19(14)30)38-22-24-11(8-37-22)10-4-6-29(2)7-5-10/h4-8,14,19H,3,9H2,1-2H3,(H3-,23,25,26,28,31,33,34)/b27-13-/t14-,19-/m1/s1

Indications

Mesh Heading Maximum Phase Reference
Bacterial Infections; Communicable Diseases; Infection Phase 3 ClinicalTrials
Cellulitis; Communicable Diseases; Infection; Skin Diseases; Skin Diseases, Infectious; Staphylococcal Skin Infections Phase 4 ClinicalTrials
Pneumonia; Pneumonia, Bacterial Phase 3 ClinicalTrials
Bacteremia Phase 4 ClinicalTrials
Pneumonia Phase 4 ClinicalTrials
Cystic Fibrosis; Fibrosis Phase 4 ClinicalTrials
Pneumonia Phase 1 ClinicalTrials
Arthritis, Infectious; Bacteremia; Endocarditis; Healthcare-Associated Pneumonia; Osteomyelitis; Pneumonia Phase 4 ClinicalTrials
Bacterial Infections; Communicable Diseases; Infection; Skin Diseases, Bacterial Phase 2 ClinicalTrials
Fractures, Bone; Fractures, Open Phase 4 ClinicalTrials
Bacterial Infections; Communicable Diseases; Infection Phase 3 ClinicalTrials
Pneumonia; Pneumonia, Bacterial Phase 4 ClinicalTrials
Infection; Surgical Wound Infection Phase 4 ClinicalTrials
Arthritis, Infectious; Communicable Diseases; Infection; Osteomyelitis Phase 4 ClinicalTrials

Related Entries

MCS

Scaffolds